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Introduction: Computed tomography pulmonary angiography (CTPA) is the test of choice for diagnosis
of pulmonary embolism (PE) in the emergency department (ED), but this test may be indeterminate for
technical reasons such as inadequate contrast filling of the pulmonary arteries. Many hospitals have
requirements for intravenous (IV) catheter size or location for CTPA studies to reduce the chances of
inadequate filling, but there is a lack of clinical data to support these requirements. The objective of this
study was to determine if a certain size or location of IV catheter used for contrast for CTPA is associated
with an increased chance of suboptimal CTPA.
Methods: This was a retrospective chart review of patients who underwent CTPA in the ED. A CTPA
study was considered suboptimal if the radiology report indicated it was technically limited or inadequate
to exclude a PE. The reason for the study being suboptimal, and the size and location of the IV catheter,
were abstracted. We calculated the rate of inadequate contrast filling of the pulmonary vasculature and
compared the rate for various IV catheter sizes and locations. In particular, we compared 20-gauge or
larger IV catheters in the antecubital fossa or forearm to all other sizes and locations.
Results: A total of 19.3% of the 1500 CTPA reports reviewed met our criteria as suboptimal, and 51.6%
of those were due to inadequate filling. Patients with a 20-gauge IV catheter or larger placed in the
antecubital fossa or forearm had inadequate filling 9.2% of the time compared to 13.2% for patients who
had smaller IVs or IVs in other locations (difference: 4.0% [95% confidence interval, -1.7%-9.7%]). There
were also no statistically significant differences in the rates of inadequate filling when data were further
stratified by IV catheter location and size.
Conclusion: We did not detect any statistically significant differences in the rate of inadequate contrast
filling based on IV catheter locations or sizes. While small differences not detected in this study may exist,
it seems prudent to proceed with CTPA in patients with difficult IV access who need emergent imaging
even if they have a small or distally located IV. [West J Emerg Med. 2019;20(2)244-249.]

INTRODUCTION
Since the publication of the Prospective Investigation
of Pulmonary Embolism Diagnosis II trial,1 computed
tomographic pulmonary angiography (CTPA) has become
the test of choice for diagnosis of pulmonary embolism (PE)
Western Journal of Emergency Medicine

in the emergency department (ED).2-3 The test characteristics
of CTPA are reported to be quite good with sensitivity and
specificity of 89% and 95%, respectively.4 While CTPA can
be highly accurate when performed with proper technique,
the reported sensitivity and specificity do not account for
244
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the times when CTPA is indeterminate because of technical
factors such as motion artifact or inadequate filling of the
pulmonary arteries.5
The American College of Radiology (ACR)
recommends a 20-gauge or larger intravenous (IV) catheter
in the antecubital fossa or forearm for CTPA.6 The ACR
recommendations do not provide supporting references,
and a literature search did not reveal published clinical data
supporting these recommendations. Nonetheless, many
hospitals have policies that follow them. While these policies
are designed to improve the quality of CTPA, in patients with
difficult IV access these policies may result in significant
delays in diagnosis while ED staff attempt to establish an IV
that follows hospital policies.
Thus, we performed a retrospective chart review
to assess if a certain location or size of the IV catheter
used for a contrast bolus for CTPA is associated with an
increased chance of inadequate filling of the pulmonary
vasculature. In particular, we sought to determine if the ACR
recommendation that a 20-gauge or larger IV catheter in the
antecubital fossa or forearm is associated with decreased rates
of inadequate filling of the pulmonary vasculature on CTPA
compared to other IV catheter sizes and locations.

Population Health Research Capsule
What do we already know about this issue?
Many hospitals have requirements for
intravenous (IV) catheter size or location for
computed tomography pulmonary angiography
(CTPA) studies to reduce the chances of a
suboptimal study, but such requirements may
result in delayed diagnosis.
What was the research question?
Is the size or location of an IV catheter used for
CTPA associated with an increased chance of
inadequate contrast filling?
What was the major finding of the study?
We did not find differences in the rate of
inadequate contrast filling of CTPAs at various
IV catheter locations or sizes.

METHODS
Study Design and Setting
This was a retrospective study performed at a single,
large, urban, county hospital in Las Vegas, Nevada. The
annual census of our adult ED is approximately 77,000. The
CTPA studies from our adult ED are rapidly read 24 hours per
day by a private group that currently employs 64 radiologists.
The standard peripheral IV catheter used in our department is
the 1.00-inch Becton Dickinson (BD) InsyteTM AutoguardTM,
which is available in sizes 16-gauge, 18-gauge, 20-gauge, and
22-gauge. In rare cases, a 2.5-inch, 18-gauge Introcan Safety®
catheter is used for ultrasound-guided deep brachial IV lines
or for placement in the internal jugular vein (“peripheral
IJs”).7 This study received approval from our hospital’s
institutional review board, which waived full review.
We identified adult patients who underwent CTPA in the
ED to evaluate for PE. We were able to identify these patients
because our radiology image-viewing software system allows
us to search for patients based upon imaging study type and
date. Patients were excluded if they had undergone CTPA
for any reason other than to rule out PE. Of the patients
meeting the inclusion criteria and not meeting the exclusion
criteria, we extracted additional patient data including basic
demographics, whether or not the CTPA was suboptimal, why
the CTPA was suboptimal (if applicable), and the size and
location of the IV line.
Two premedical student research assistants functioned as
data abstractors. They were blinded from the study objectives,
and they used standardized data collection forms to perform
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How does this improve population health?
It may be prudent to proceed with CTPA in
patients with difficult IV access who need
emergent imaging even if they have a small or
distally located IV.

chart reviews. Each data abstractor was trained through the
review of 20 sample charts with a physician investigator.
They assessed each final, attending radiology impression to
determine if the CTPA met our definition of “suboptimal.”
We considered a CTPA suboptimal if the final radiology
impression read any of the following: inadequate filling/
suboptimal timing of the contrast bolus; motion artifact; or
any case the radiology impression called the study technically
limited or inadequate to exclude a PE. However, impressions
stating inability to exclude subsegmental PE were not included
as suboptimal, since subsegmental PEs may not need to be
treated.8 Note that our definition of “suboptimal” is consistent
with prior literature on this topic.9
The data abstractors were periodically monitored, and
a physician investigator audited 50 charts from each of the
abstractors to assess for accuracy. Also, both abstractors
reviewed a sample of 50 charts to assess the inter-rater
reliability for the study.
All CTPA studies were performed on a 64-slice scanner
(Siemens Medical Solutions USA Inc; Malvern, PA) with
a standard CTPA protocol at the hospital where data were
collected. This includes a localizer sequence through the
carina followed by a timing bolus of 30-cubic centimeter (cc)
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contrast bolus of Optiray 350 (Ioversol 74%; Guerbet LLC;
Princeton, New Jersey) to localize the pulmonary arteries until
the maximum Hounsfield unit is measured. A 90-cc bolus is
then injected at 4-5 cc/sec both preceded and followed by a
50-cc saline flush given through a power injector. Continuous
0.6 millimeter (mm) axial slices are taken from above the
apices to below the costophrenic angles with an inspiratory
hold. Our hospital’s protocol calls for 20-gauge IV access
or greater at the antecubital fossa or forearm, but this can
be overridden by the attending physician based on emergent
indications. Pursuant to protocol, radiology technicians
use a 10-cc normal saline flush to evaluate access prior to
administration of contrast. Additional scanning parameters are
as follows: 120 kilovolt peak (kVp), 2 x 2 mm reconstruction,
pitch of 0.8-1.0, and coronal and sagittal multiplanar
reformation of 3 x 3 mm.
Outcomes and Data Analysis
As discussed below, we decided to review a sample of
1500 CTPA studies. After review, we calculated the percentage
of all CTPA studies that were suboptimal, and determined
the fraction of those suboptimal studies that were due to
inadequate filling of the pulmonary vasculature.
The primary outcome for the study was meant to assess
the ACR’s recommendations for IV size and location for
CTPA. In particular, we aimed to measure the difference in
the rate of inadequate filling of the pulmonary vasculature for
20-gauge or larger catheters in the antecubital fossa or forearm
compared to the rate of inadequate filling for all other catheter
size and location combinations.
Secondarily, the percentage of studies with inadequate filling
of the pulmonary vasculature were stratified by IV catheter
size and location. We compared the percentage of studies with
inadequate filling when a 20-gauge or larger IV catheter was used
to the percentage of studies with inadequate filling when smaller
catheters were used. Also, the rate of inadequate filling was
compared for IV catheters placed in the forearm or antecubital
fossa to IV catheters placed at other locations.
Our initial choice of a sample size of 1500 was based on the
size of a previously published study about suboptimal CTPAs9
and gestalt that this would be sufficiently large. Since no prior
study has evaluated the relationship between IV size or location
and suboptimal CTPAs, we initially did not have sufficient
information to perform a formal power calculation. However,
with the knowledge of the results of this study, we can provide
a post-hoc power analysis as follows: for the primary outcome,
assuming that patients would have an IV catheter meeting the
ACR recommendations six times as often as not, we found that
at least 132 patients would be required in the group not meeting
the ACR recommendations to find a 10% difference in the rate of
inadequate contrast filling of the pulmonary vasculature with a
power of 0.8 and an alpha of 0.05.
Data were collected and analyzed via Microsoft Excel
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(Version 15, Microsoft, Redmond, Washington). We
performed statistical analysis using “R” (version 3.5.2, R
Foundation, Vienna, Austria). The proportions for each group
were compared using Fisher’s exact test.
RESULTS
A total of 1500 consecutive CTPA studies to assess for PE
in our ED from June 2016 to March 2017 were identified and
included for analysis. The patients upon which these studies were
performed were 48.2% female. The median age was 55 years
(interquartile range [IQR]: 42-65), and the median body mass
index was 28 (IQR: 24-34). The patients were 56.8% Caucasian,
23.7% African American, 12.8% Hispanic, and 5.0% Asian.
Of the 1500 studies, 289 (19.3% [95% confidence interval
{CI}, 17.3-21.4%]) met our criteria for suboptimal. Of the
suboptimal studies, 51.6% (147/289) were due to an inadequate
filling of the pulmonary vasculature. Table 1 shows the reasons

Table 1. Reasons for suboptimal CTPA studies.
Reason for suboptimal study

Percent of suboptimal studies

Motion artifact

54.3% (157/289)

Inadequate filling

51.6% (147/289)

Other

2.1% (6/289)

Multifactorial
11.4% (33/289)
CTPA, computed tomography pulmonary angiography.

why the CTPA studies were considered suboptimal.
Inter-rater reliability was determined based on the assessment
of whether or not the CTPA was suboptimal from a sample of
50 charts, and Cohen’s kappa was 0.92 between the two student
abstractors. A physician auditor abstracted 100 charts (50 done
by each abstractor) to assess the inter-rater reliability between the
physician and each of the abstractors. The two additional Cohen’s
kappa values were calculated at 0.92 and 0.96.
Regarding the primary outcome, patients with a 20-gauge
or larger IV catheter placed in the antecubital fossa or forearm
(the ACR recommendations) had inadequate filling 9.2% of
the time (81/883) compared to 13.2% (20/152) for patients
who had smaller IVs or IVs in other locations. The difference
of 4.0% (95% CI, -1.7%-9.7%) is not statistically significant.
When a patient had an IV catheter in the antecubital fossa
or forearm, the rate of inadequate filling of the pulmonary
vasculature was 9.3% (83/888), compared to 12.2% (18/147)
in other IV locations. The difference between these groups was
2.9% (95% CI, -2.7%-8.5%), which is not statistically significant.
Only 13 patients had 22-gauge IV catheters for CTPA,
but a comparison of the rate of inadequate filling for 22-gauge
IV catheters (23.1 %) to larger catheters (9.7%) revealed a
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difference of 13.4% (95% CI, -9.6%-36.4%).
Unfortunately, the IV catheter location used for CTPA
was not specified in the chart in 465 of the 1500 studies, and
in 464 cases the size of the IV catheter used was not recorded.
In an attempt to assess for bias that may have been introduced
into the study from the missing IV data, we performed an
additional analysis and found that the rate of inadequate
contrast filling was nearly identical for patients who had an
IV size recorded (9.9%) compared to those with missing data
(9.7%). Similarly, the rates of inadequate contrast filling were
nearly equal for patients with an IV location recorded (9.8%)
and those without an IV location recorded (9.9%).
The chance of inadequate filling of the pulmonary
vasculature was determined for each IV catheter size and

Table 2. Intravenous (IV) catheter location and rate of inadequate
pulmonary vasculature filling.
Total # (%)

Rate of inadequate filling

Antecubital

IV location

669 (64.6%)

62/669 (9.3%)

Forearm

219 (21.2%)

21/219 (9.6%)

Neck

38 (3.7%)

3/38 (7.9%)

Hand

38 (3.7%)

7/38 (18.4%)

Wrist

37 (3.6%)

4/37 (10.8%)

Upper arm

19 (1.8%)

2/19 (10.5%)

Central line

12 (1.2%)

2/12 (16.7%)

3 (0.3%)

0/3 (0%)

Leg

Table 3. Intravenous (IV) catheter size and rate of inadequate
pulmonary vasculature filling.
IV size

Total # (%)

Rate of inadequate filling

16-gauge

3 (0.3%)

0/3 (0%)

18-gauge

316 (30.5%)

33/316 (10.4%)

20-gauge

704 (68.0%)

66/704 (9.4%)

22-gauge

13 (1.3%)

3/13 (23.1%)

location, as listed in Tables 2 and 3.
DISCUSSION
To our knowledge, this is the largest study to evaluate
the rate of suboptimal CTPA, and the only study to attempt
to determine if a certain IV size or location is associated with
an increased chance of inadequate filling of the pulmonary
vasculature resulting in a suboptimal study. We found a
fairly high rate of suboptimal CTPA, 19.3%. This number is
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substantially higher than the 4% found in a study by Bates et
al. that used a similar definition of “suboptimal.”9 The chart
review methods in that study were not as rigorous as ours, and
we suspect the true suboptimal rate is higher than 4%.
While no other recent study has looked at the rate of
suboptimal CTPA as it is defined in our study and the one
by Bates et al, some other studies related to this issue are of
note. For example, a study by Molaee et al. found that 7.9%
of CTPA studies were of “unsatisfactory technique,” such that
they could not be adequately interpreted.10 An older study
from 2004 found that an artifact called “transient interruption
of contrast” occurs in 37% of CTPA studies, limiting the
radiologist’s ability to interpret the study.11 Additionally,
another recent study related to this subject found that 9.5% of
CTPA studies were “technically limited.”12 In the end, because
of variations in local radiology practice styles, differences
in technique for the execution of CTPA, and differences in
equipment, the rate of suboptimal CTPA likely varies a bit
from hospital to hospital.
Regardless of the exact rate of suboptimal CTPA, there is
some consensus from previous studies9-11 and this study that
inadequate filling of the pulmonary vasculature accounts for a
large portion of the suboptimal CTPAs. Since suboptimal CTPAs
could lead to unnecessary anticoagulation and additional testing,
it is important to minimize the chances of a suboptimal CTPA.
Thus, it makes sense to put forth recommendations
about the IV size and location if these recommendations will
reduce the frequency of suboptimal CTPA. While our study
does show trends toward reductions in the rate of inadequate
filling of the pulmonary vasculature when larger IVs in the
antecubital fossa or forearm are used, the difference in the
rates of inadequate filling for various IV sizes and locations
appears to be small. Moreover, even patients with ideally
located, 18-gauge IV catheters have inadequate filling of the
pulmonary vasculature about one in 10 times, suggesting that
factors other than the IV size and location affect the quality of
the contrast bolus.
While our sample size for patients with 22-gauge IVs
was very small, it is notable that 10 of 13 patients with these
small IVs had CTPAs with completely adequate filling of
the pulmonary vasculature. Interestingly, the packaging
for a 22-gauge BD InsyteTM AutoguardTM catheter lists the
maximum flow rate as 35 mL per minute, which should not
allow for the standard rapid contrast bolus of 4-5 cc/second
for a CTPA. However, through direct communication with
BD Medical, we confirmed that the maximum listed flow rate
is the gravity flow rate, and they claim that the BD InsyteTM
AutoguardTM can be safely used for power injection as long
as the pressure is limited to 300 pounds per square inch.
Moreover, prior data suggests that 22-gauge peripheral IV
catheters can tolerate the high flow rates from power injection
without risking material damage.13
Thus, 22-gauge IV catheters can likely be safely and
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adequately used for CTPA, and some data suggest that even
intraosseous lines can be used for CT angiography. A tibial
intraosseous line has been reported to have been used for
successful administration of contrast for a CTPA study, with
excellent opacification of the pulmonary arteries,14 and a
humeral intraosseous line been successfully used for a CT
angiogram of the chest and abdomen.15
With regard to the use of unusual IV locations for CTPAs,
the data we found for neck IVs are small but interesting. In
these cases, neck IVs refer to external jugular vein IVs and
peripheral IVs, and IVs in this location had very low rates
of inadequate contrast filling of the pulmonary vasculature.
Perhaps this is due to the nearly direct route from the external
or internal jugular vein to the superior vena cava. A potential
downside to the use of neck lines for CTPAs is that contrast
extravasation may be more dangerous in the neck than in other
locations of the body, but this was not assessed in our study.
The hospital where this study was performed allows the
physician to proceed with CTPA even if the IV is smaller
than recommended or not in the antecubital fossa or forearm
in emergent situations. Based upon the results of our study,
this appears to be a reasonable and important exception to the
ACR recommendations for IV size and location. We hope that
CTPA will not be delayed in an unstable patient with difficult
IV access just because the IV size or location does not meet
the recommendations. If the line is tested before contrast
injection with a saline flush, there is no resistance, and there
are no other easily obtainable IV access sites, it is reasonable
to proceed with CTPA regardless of the IV size or location.
LIMITATIONS
Our study had several limitations. First, this was a
retrospective study, which raises the possibility of confounders
and unrecognized bias. Second, this was a single-center
study with a single radiology group, which limits the external
validity of the study. Additionally, while the study was
adequately powered for the primary outcome, our sample
sizes for some of the secondary outcomes were small. Thus,
the data trends we observed may have become statistically
significant with larger sample sizes.
Next, there was a fair amount of missing data in our IV
size and location in analysis. However, our analysis of the
missing data found that the rates of inadequate filling of the
pulmonary vasculature were nearly identical for those patients
with missing data compared to those with complete data
for IV size and location. This suggests that the missing data
would have been unlikely to have made a dramatic change
to our results. Another issue related to missing data regards
IV catheter length. Although the IV catheter length could be
related to the rate of inadequate filling, the IV catheter length
is generally not recorded in our electronic health record
system. Therefore, we could not do a formal analysis of IV
catheter length. However, central lines (which are, of course,
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longer than typical peripheral IV catheters) were separated
out from the peripheral IVs in our analysis. Also, we know
that the only available long IV catheter in our department is
a 20-gauge, and this catheter is only used for upper arm and
neck IV-line placement. With this information, the maximum
possible number of long IV catheters was 23, making up only
2% of the total sample of 20-gauge or larger IV size group.
Thus, variable IV catheter length was not much of a factor in
our study.
CONCLUSION
Suboptimal CTPA reports occurred nearly 20% of the time
in this study, more than half of which were due to inadequate
filling of the pulmonary vasculature. While larger IVs in the
antecubital fossa or forearm may slightly reduce the rate of
inadequate contrast filling of the pulmonary arteries, we were
unable to find any statistically significant differences in the
rates of inadequate filling based on IV size or location. In
emergent situations, the physician should proceed with CTPA
even if an IV line meeting the ACR recommendations cannot
be established.
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